Bill
HR 5880
The Fight Illicit Pill Presses Act strengthens regulations and penalties against illegal pill presses, protecting public health from counterfeit medications.
The Fight Illicit Pill Presses Act (HR 5880) aims to combat the growing issue of illicit pill presses that are used to manufacture counterfeit and dangerous prescription medications. The bill seeks to enhance regulatory measures and impose stricter penalties on individuals and entities involved in the illegal production of these pills, thereby protecting public health and safety.
The bill includes several important provisions designed to address the issue of illicit pill presses:
Regulatory Framework: Establishes a comprehensive regulatory framework for the registration and oversight of pill press manufacturers and distributors.
Penalties: Introduces enhanced penalties for the illegal manufacture and distribution of counterfeit medications, including increased fines and potential imprisonment for offenders.
Reporting Requirements: Mandates that manufacturers and distributors of pill presses report any suspicious activities or transactions to law enforcement agencies.
Collaboration with Law Enforcement: Encourages collaboration between federal, state, and local law enforcement agencies to effectively monitor and investigate illicit pill press operations.
Public Awareness Campaigns: Allocates funding for public awareness campaigns to educate the public about the dangers of counterfeit medications and how to identify them.
The Fight Illicit Pill Presses Act would primarily affect:
Manufacturers and Distributors: Entities involved in the production and distribution of pill presses will face stricter regulations and oversight.
Law Enforcement Agencies: Local, state, and federal law enforcement will be tasked with enforcing the new regulations and investigating illicit activities.
Public Health: The general public will benefit from increased safety measures and reduced access to counterfeit medications, which can pose serious health risks.
Introduced Date: The bill was introduced in the House on October 31, 2025.
Committee Referrals: Upon introduction, HR 5880 was referred to the Committee on Energy and Commerce and the Committee on the Judiciary for further consideration. The timeline for these committees to review the bill will be determined by the Speaker of the House.
The Fight Illicit Pill Presses Act represents a proactive approach to addressing the serious issue of counterfeit medications produced by illicit pill presses. By enhancing regulatory measures and penalties, the bill aims to safeguard public health and ensure that individuals have access to safe and legitimate medications. The ongoing legislative process will determine the final form and implementation of this important legislation.
Compiled from official sources — confirm details with the bill’s official record.
Sign in to ask a question.
